Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date The Importance of Accurate Chemical Characterization of Medical Devices... Ron Brown, Toxicologist at Risk Science Consortium and Dries Cardoen, PhD, Sr. E&L Expert – Team leader at Nelson Labs Full title: The Importance of Accurate Chemical Characterization of Medical Devices Extractables Chemical characterization of medical devices, involv... 4 months ago | 134 mins Transformation of Toxicology data into Specific PDE’s Kim Li, PhD, DABT, MPH, Amgen Inc and Dries Cardoen, Team Leader of Study Directors at Nelson Laboratories, LLC Presented by Kim Li, PhD, DABT, MPH, Amgen Inc. Followed by an industry perspective presented by Dries Cardoen, Team Leader of Study Directors - Inha... 3 years ago | 92 mins How Clinical Laboratories Save Money & Help Physicians Become Patient-Centric Jeffrey Reid, Tony McCraney Value-based healthcare policies continue driving the healthcare market away from a fee-for-service model and more toward an enhanced patient managemen... 4 years ago | 30 mins Leverage PK data in PharmaPendium to inform drug development strategies Marnix Wieffer Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more succes... 3 years ago | 49 mins Current Progress in Approaches for The Safety Assessment of E&L Kim Li, PhD, DABT, MPH, Amgen Inc.& Erica J. Tullo, Technology Manager, E&L – Analytical Labs, West Pharmaceutical Service Title: Current Progress in Approaches for The Safety Assessment of E&L Presenter: Kim Li, PhD, DABT, MPH, Amgen Inc Summary: This Webinar will review ... 5 years ago | 75 mins Comparison of Hemoglobin A1c Test Methods in the Clinical Lab Brooke Medaugh Clinical laboratories must provide precise and accurate results while managing increasing test volumes and shrinking reimbursement rates. The importa... 5 years ago | 30 mins Constrained bicyclic peptide delivery of toxin & immune agonists to solid tumors Johanna Lahdenranta, PhD, Director, In Vivo Pharmacology, Bicycle Therapeutics We have developed tumor-targeted toxin conjugates (Bicycle toxin conjugates, BTCs) as well as tumor targeted immune cell agonists (TICAs™) based on co... 3 years ago | 32 mins 3D Nephrotoxicity applications & Nortis’ microfluidic organ-on-chip technology Dr. Ed Kelly, Dr. Henning Mann 1. The kidney proximal tubule is the primary site of drug-induced nephrotoxicity. I will describe the development of a 3-dimensional flow-directed pro... 6 years ago | 97 mins Publishing your Research: Enhancing Transparency and Rigor Natalia Ortuzar and Eric M. Prager Publish with integrity! This webinar will explore strategies to ensure your scientific findings meet the necessary standards of transparency and repro... 5 years ago | 58 mins Introduction into PharmaPendium: informed decision making during development Marnix Wieffer Optimal decisions making during pharmaceutical development critically relies on high quality data. PharmaPendium is the go-to database to access extra... 3 years ago | 43 mins
